658 related articles for article (PubMed ID: 31013394)
1. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
[TBL] [Abstract][Full Text] [Related]
2. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
3. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of a noninterruptive alert to increase prescription of take-home naloxone in emergency departments.
Jennings LK; Ward R; Pekar E; Szwast E; Sox L; Hying J; Mccauley J; Obeid JS; Lenert LA
J Am Med Inform Assoc; 2023 Mar; 30(4):683-691. PubMed ID: 36718091
[TBL] [Abstract][Full Text] [Related]
5. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of patterns of opioid overdose and interventions delivered at a tertiary hospital emergency department: impact of COVID-19.
Potaka KL; Freeman R; Soo D; Nguyen NA; Sim TF; Moullin JC
BMC Emerg Med; 2022 Apr; 22(1):62. PubMed ID: 35397487
[TBL] [Abstract][Full Text] [Related]
7. Development of a take-home naloxone program at an urban academic emergency department.
Eswaran V; Allen KC; Cruz DS; Lank PM; McCarthy DM; Kim HS
J Am Pharm Assoc (2003); 2020; 60(6):e324-e331. PubMed ID: 32690447
[TBL] [Abstract][Full Text] [Related]
8. Yes, not now, or never: an analysis of reasons for refusing or accepting emergency department-based take-home naloxone.
Kestler A; Giesler A; Buxton J; Meckling G; Lee M; Hunte G; Wilkins J; Marks D; Scheuermeyer F
CJEM; 2019 Mar; 21(2):226-234. PubMed ID: 29789030
[TBL] [Abstract][Full Text] [Related]
9. Efforts to Improve Naloxone Co-Prescription for Patients With Cancer Pain at Risk of Opioid Overdose.
Amaram-Davila J; Reddy A; Arthur J; Narayanan S; Gogineni M; Mallipeddi T; De Moraes AR; Maddi R; Shelal Z; Urbauer D; Chen M; Bruera E
J Palliat Med; 2023 Jul; 26(7):969-973. PubMed ID: 37074064
[No Abstract] [Full Text] [Related]
10. Implementing an overdose education and naloxone distribution program in a health system.
Devries J; Rafie S; Polston G
J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
[TBL] [Abstract][Full Text] [Related]
11. Safety of a Modified Community Trailer to Manage Patients with Presumed Fentanyl Overdose.
Scheuermeyer FX; Grafstein E; Buxton J; Ahamad K; Lysyshyn M; DeVlaming S; Prinsloo G; Van Veen C; Kestler A; Gustafson R
J Urban Health; 2019 Feb; 96(1):21-26. PubMed ID: 30324356
[TBL] [Abstract][Full Text] [Related]
12. Rhode Island's Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment.
Samuels EA; Wentz A; McCormick M; McDonald JV; Marshall BDL; Friedman C; Koziol J; Alexander-Scott NE
Ann Emerg Med; 2021 Jul; 78(1):68-79. PubMed ID: 33865617
[TBL] [Abstract][Full Text] [Related]
13. Adoption and Utilization of an Emergency Department Naloxone Distribution and Peer Recovery Coach Consultation Program.
Samuels EA; Baird J; Yang ES; Mello MJ
Acad Emerg Med; 2019 Feb; 26(2):160-173. PubMed ID: 30074673
[TBL] [Abstract][Full Text] [Related]
14. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
15. Impact of an emergency department opioid prescribing guideline on emergency physician behaviour and incidence of overdose in the Saskatoon Health Region: a retrospective pre-post implementation analysis.
Hartmann RJ; Elder JD; Terrett LA
CMAJ Open; 2021; 9(1):E79-E86. PubMed ID: 33514601
[TBL] [Abstract][Full Text] [Related]
16. Emergency Physicians and Opioid Overdoses: A Call to Aid.
Houry D; Adams J
Ann Emerg Med; 2019 Sep; 74(3):436-438. PubMed ID: 31402152
[No Abstract] [Full Text] [Related]
17. Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis.
Katzman JG; Greenberg NH; Takeda MY; Moya Balasch M
J Addict Med; 2019; 13(2):131-138. PubMed ID: 30303890
[TBL] [Abstract][Full Text] [Related]
18. Access and Barriers to Take-Home Naloxone Use among Emergency Department Patients with Opioid Misuse in Baltimore, Maryland, USA.
Hurt BR; Hussain A; Aledhaim A; Moayedi S; Schenkel SM; Kim HK
Subst Use Misuse; 2020; 55(13):2237-2242. PubMed ID: 32729772
[TBL] [Abstract][Full Text] [Related]
19. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.
Sajwani HS; Williams AV
Harm Reduct J; 2022 Oct; 19(1):117. PubMed ID: 36266701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
